Abstract

ObjectivesThe EUSCREEN study compares the cost-effectiveness of paediatric hearing screening programmes and aims to develop a cost-effectiveness model for this purpose. Alongside and informed by the development of the model, neonatal hearing screening (NHS) is implemented in Albania. We report on the first year. MethodsAn implementation plan was made addressing objectives, target population, screening protocol, screener training, screening devices, care pathways and follow up. NHS started January 1st, 2018 in four maternity hospitals: two in Tirana, one in Pogradec and one in Kukës, representing both urban and rural areas. OAE-OAE-aABR was used to screen well infants in maternity hospitals, whereas aABR-aABR was used in neonatal intensive care units and in mountainous Kukës for all infants. Screeners’ uptake and attitudes towards screening and quality of screening were assessed by distributing questionnaires and visiting the maternity hospitals. The result of screening, diagnostics, follow up and entry into early intervention were registered in a database and monitored. ResultsScreeners were keen to improve their skills in screening and considered NHS valuable for Albanian health care. The number of “fail” outcomes after the first screen was high initially but decreased to less than 10% after eight months. In 2018, 11,507 infants were born in the four participating maternity hospitals, 10,925 (94.9%) of whom were screened in the first step. For 486 infants the result of screening was not registered. For the first screen, ten parents declined, eight infants died and one infant was discharged before screening could be performed. In 1115 (10.2%) infants the test either could not be performed or the threshold was not reached; 361 (32,4%) of these did not attend the second screen. For the third screen 31 (34.4%) out of 90 did not attend. Reasons given were: parents declined (124), lived too far from screening location (95), their infant died (11), had other health issues (7), or was screened in private clinic (17), no reason given (138). ConclusionsImplementation of NHS in Albania is feasible despite continuing challenges. Acceptance was high for the first screen. However, 32.4% of 1115 infants did not attend the second screen, after a “fail” outcome for the first test.

Highlights

  • The EUSCREEN study [1] compares the cost-effectiveness of paediatric vision and hearing screening programmes and aims to develop a cost-effectiveness model for this purpose

  • Acceptance of the first screen has been found to vary between 90.85% (China [11]) and 99.8% (Singapore [8]) (Table 1), out of all infants screened in the first screen, the percentage that was invited for a second screen varied between 1.7% [7] and 14.3% [9], whereas nonattendance for the second screen varied between 0.1% in France [2] and 51.6% in Nigeria [9]

  • We report on the first year of implementation of a neonatal hearing screening (NHS) programme as part of the EUSCREEN project in three provinces in Albania (Tirana, Pogradec and Kukës) that started on January 1st, 2018

Read more

Summary

Introduction

The EUSCREEN study [1] compares the cost-effectiveness of paediatric vision and hearing screening programmes and aims to develop a cost-effectiveness model for this purpose. Alongside the development of the model and informed by its preliminary predictions, neonatal hearing screening (NHS) is being implemented in Albania, where hearing screening is not yet routinely performed. Studies that report on implementation of NHS can be retrospective [2,3,4] or prospective [5,6,7,8,9,10,11,12] cross-sectional studies. They mainly report on the outcomes related to the screening programme, such as coverage, referral rates and attendance rates. Between 4.6% [2] and 64.6% [5] did not attend diagnostic assessment

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.